Home › Kanser sa Ovary › California › Santa Monica
Pag-aaral pangklinika para sa Kanser sa Ovary sa Santa Monica, CA
Isang pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Santa Monica. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Saint John's Cancer Institute, Santa Monica
A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi ang layo
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
- UCLA Medical Center, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Kivu Trial Site, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6 mi ang layo
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Nagre-recruitPhase 1/2
- Research Site, Santa Monica
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Nagre-recruitPhase 3
- Site 0104, Beverly Hills · 6 mi ang layo
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Nagre-recruit
- Tower Cancer Research Foundation, Beverly Hills · 6 mi ang layo
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi ang layo
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mi ang layo
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi ang layo
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Nagre-recruitPhase 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Nagre-recruitPhase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Nagre-recruitPhase 1
- University of California, Los Angeles, Santa Monica
A Beta-only IL-2 ImmunoTherapY Study
Nagre-recruitPhase 1/2
- Providence Saint John's Health Center, Santa Monica
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY69 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- San Antonio, TX31 pag-aaral
- Cleveland, OH30 pag-aaral
Iba pang pag-aaral sa Santa Monica
- Non-Small Cell Lung Cancer45 pag-aaral
- Kanser sa Suso28 pag-aaral
- Colorectal Cancer23 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Metastatic Cancer19 pag-aaral
- Kanser sa Baga15 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg13 pag-aaral
- Pagkabigo ng Puso11 pag-aaral
- Kanser ng Endometrium10 pag-aaral
- Kanser sa Tiyan9 pag-aaral
- Kanser sa Pancreas9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.